CMC is where biotech programs die on the way to commercial supply — and CMC leadership hires are the most consequential technical hires most venture-backed biotechs will make before their pivotal trial. Recruits Lab runs CMC searches with recruiters who understand the tech-transfer, GMP scale-up, and regulatory strategy realities of your specific modality.
CMC is the function that determines whether a promising molecule actually becomes a drug. A weak CMC hire shows up as IND delays, scale-up failures, supply interruptions, and regulatory observations. The cost of a wrong CMC director is rarely the recruiting fee — it is a missed IND date or a stalled commercial launch.
Recruits Lab places CMC leadership and specialists across the full functional spectrum: process development (upstream and downstream), analytical development, formulation, MSAT, drug substance and drug product manufacturing, CMC strategy, and CMC regulatory. Our practice spans small molecule, biologics, ADCs, peptides, RNA therapeutics, cell therapy, and gene therapy.
Our recruiters understand the distinctions that matter — process candidates with real scale-up ownership versus contributors, formulation scientists with route-specific expertise versus generalists, and CMC strategy leaders with successful IND and BLA filings versus those who have only supported them. We screen for the experience that maps to your specific modality and stage.
We work both single-hire and team-build engagements. A subscription engagement scales to a multi-role CMC build ahead of IND or pivotal supply. A contingency engagement is the right fit for a single senior addition. Both carry a 90-day replacement guarantee.
Subscription pricing is what makes specialized CMC search affordable for venture-backed teams. The economics free hiring leaders to make the right hire rather than the cheapest one to source.
Why this market is hard to recruit for. And how we solve each one.
ADC, LNP, mRNA, AAV, and autologous cell therapy CMC are all distinct. We map candidates to your modality, not a generic 'biologics' bucket.
Many process candidates have supported scale-up; fewer have owned a successful tech transfer. We screen for ownership.
IND and BLA CMC authoring is rarer than resumes suggest. We assess for direct authoring versus contribution.
Most biotechs run CMC through CDMOs. We screen for the supplier oversight and tech transfer experience that scales.
Big pharma CMC leaders often struggle with venture-backed pace. We screen for the cultural shift.
Senior CMC talent is courted constantly. We manage offer and resign conversations directly.
The repeatable system behind our 14-day average hire time.
We run a deep intake call with hiring managers and scientific leadership covering technical must-haves, dealbreakers, comp band, equity philosophy, and the cultural traits that predict success in your specific stage and program.
We build a fresh map of 80-150 qualified candidates from direct competitors, academic spinouts, CROs, and adjacent therapeutic areas. No database scraping — real research from a recruiter who understands the science.
Personalized outreach from a senior recruiter who can actually discuss your molecule, mechanism, or modality. Response rates run 3-5x higher than generalist agencies because the first message reads like it came from another scientist.
Five to eight vetted candidates with structured profile briefs covering technical fit, motivation, publication record where relevant, comp expectations, and risk factors. Not a resume dump — a decision document.
We manage offer construction, counter-offer scenarios, resign coaching, and start-date negotiation. Every placement carries a 90-day replacement guarantee at no additional fee.
Original observations from live searches in this specialty.
CMC leaders who have personally shepherded a tech transfer from internal to CDMO or from CDMO A to CDMO B carry knowledge that cannot be trained. We prioritize this specific experience on Director-and-above CMC shortlists over almost every other qualification.
The CMC director who built your first GMP batches at pre-IND is often not the right person to run pivotal supply. Scaling from clinical to commercial requires a different operating tempo, different regulatory posture, and different vendor management. We flag this at intake so companies do not lose 9 months on the wrong hire.
A biologic CMC director is not a small-molecule CMC director. A cell therapy CMC director is not either. Job descriptions that hedge on modality routinely under-shortlist because the maps are genuinely separate. We push modality-specificity in intake.
2026 U.S. base salary ranges for cmc roles at venture-backed and mid-cap life sciences companies. Excludes equity, bonus, and sign-on. Ranges reflect Series A through commercial-stage benchmarks.
| Role | Base Salary Range |
|---|---|
| Senior Scientist, Process Dev | $145K–$190K |
| Principal Scientist, CMC | $180K–$235K |
| Manager, MSAT | $160K–$210K |
| Associate Director, CMC | $200K–$260K |
| Director, CMC | $220K–$290K |
| Senior Director, CMC | $260K–$340K |
| VP, CMC | $330K–$435K |
Source: Recruits Lab 2026 Life Sciences Compensation dataset.
Quick answers to the questions founders and hiring leaders ask most.
CMC recruiters source, screen, and qualify chemistry, manufacturing, and controls talent for biotech and pharma — process development, analytical, formulation, MSAT, and CMC strategy. Recruits Lab specializes in CMC and averages 14 days from kickoff to offer.
Industry average for director and VP-level CMC is 100 to 180 days. Recruits Lab averages 14 days through active sourcing and disciplined interview cadence.
Yes. Biologics, ADCs, cell therapy, and gene therapy CMC are all core practice areas with modality-specific recruiters.
Subscription starts at $7,500 per month with unlimited active roles. Contingency is a flat 20 percent with a 90-day guarantee.
Yes. Multi-hire IND-enabling CMC builds are a routine engagement on subscription.
Director of CMC with autologous cell therapy process experience needed ahead of IND. Two retained firms had failed across seven months.
Mapped 36 autologous cell therapy CMC leaders nationally. Senior recruiter ran outbound, presented a five-person shortlist in 12 days including two with successful IND filings.
Offer accepted in 24 days. IND filed on the original timeline.
"Recruits Lab understood the science from day one. They sent four interview-ready candidates inside two weeks after our internal team had spent three months on the role."
"Their subscription model let us close three scientific hires in a single quarter for less than what a single retained search would have cost us."
Yes. CMC regulatory affairs is a frequent adjacent search to operational CMC.
Yes. CDMO CMC leadership and technical operations are part of the practice.
Yes. Both are routine practice areas.
Yes. We screen specifically for tech transfer ownership experience.
Yes. Small molecule CMC including continuous manufacturing is part of the practice.
Every placement carries a 90-day replacement guarantee. If a hire leaves or does not work out within the first 90 days, we run the search again at no additional fee.
Yes. We sign NDAs and routinely run confidential and stealth-mode searches for executive replacements, sensitive program leads, and pre-launch hires.
Book a free 30-minute hiring strategy review using the CTA on this page. We will scope the role, suggest a sourcing approach, and quote a subscription or contingency option that fits your stage.
Compensation data, hiring playbooks, case studies, and related recruiting specialties.
Four ways to engage. Pick whichever matches where you are.
30-minute strategy review with a senior recruiter. Free, no commitment.
Get startedTell us about the role. We respond with a calibration call within 24 hours.
Get startedSend a job description. We confirm fit and quote a subscription or contingency engagement.
Get startedSenior candidates: get represented to our active hiring pipeline.
Get startedRelated Resources
Hand-picked salary guides, market reports, and recruiter pages related to this topic. Authored by Darren Nelson and the Recruits Lab team.
Schedule a free 30-minute Hiring Strategy Review and walk away with a clear plan tailored to your roles.